We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAC icon
2376
TransAlta
TAC
$3.95B
$641K 0.01%
61,841
-7,844
-11% -$80.9K
NGMS
2377
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$641K 0.01%
+41,561
New +$870K
MT icon
2378
ArcelorMittal
MT
$56.3B
$640K 0.01%
19,996
+11,285
+130% +$362K
OSG
2379
Octave Specialty Group
OSG
$207M
$638K 0.01%
61,302
+22,501
+58% +$305K
UTHR icon
2380
United Therapeutics
UTHR
$22.2B
$638K 0.01%
3,557
-9,346
-72% -$1.78M
GRP.U
2381
DELISTED
Granite Real Estate Investment Trust
GRP.U
$637K 0.01%
8,244
+3,944
+92% +$300K
RXRX icon
2382
Recursion Pharmaceuticals
RXRX
$1.76B
$635K 0.01%
88,748
+54,971
+163% +$584K
IBCP icon
2383
Independent Bank Corp
IBCP
$845M
$634K 0.01%
+28,829
New +$693K
PRU icon
2384
Prudential Financial
PRU
$42.2B
$632K 0.01%
5,349
-30,058
-85% -$3.42M
CLF icon
2385
CALL
Cleveland-Cliffs
CLF
$6.92B
$631K 0.01%
+19,600
New +$447K
X
2386
CALL
DELISTED
US Steel
X
$630K 0.01%
+16,700
New +$452K
GGB icon
2387
Gerdau
GGB
$9.38B
$629K 0.01%
123,165
-124,192
-50% -$533K
EGRX
2388
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$627K 0.01%
12,679
+4,356
+52% +$209K
TSPQ
2389
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
$627K 0.01%
64,264
+24,155
+60% +$235K
GGAL icon
2390
Galicia Financial Group
GGAL
$7.15B
$626K 0.01%
57,980
+25,638
+79% +$247K
COHU icon
2391
Cohu
COHU
$2.62B
$625K 0.01%
21,115
-15,487
-42% -$495K
ELP
2392
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$625K 0.01%
99,886
+69,182
+225% +$362K
STN icon
2393
Stantec
STN
$8.43B
$625K 0.01%
12,459
+8,784
+239% +$455K
TIXT
2394
DELISTED
TELUS International
TIXT
$624K 0.01%
25,193
+10,887
+76% +$288K
NVRI icon
2395
Enviri
NVRI
$555M
$623K 0.01%
50,883
+36,153
+245% +$531K
APRN
2396
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$623K 0.01%
12,812
+6,761
+112% +$491K
GBX icon
2397
The Greenbrier Companies
GBX
$1.41B
$622K 0.01%
12,067
-5,950
-33% -$268K
HCI icon
2398
HCI Group
HCI
$2.29B
$621K 0.01%
9,102
-2,496
-22% -$171K
KR icon
2399
CALL
Kroger
KR
$34.3B
$620K 0.01%
+10,800
New +$536K
MARA icon
2400
Marathon Digital Holdings
MARA
$3.73B
$619K 0.01%
22,129
-857
-4% -$22.3K

Similar funds

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.